Vision-Sciences Inc.
CGNT
$8.01
$0.040.50%
Recommendation
--
Prev Close
--
Volume
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
--
| Weiss Ratings | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price (Date) | -- | |||
| Valuation | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | -- | |||
| Dividends and Shares | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 845-365-0600 | |||
| Address | 40 Ramland Road South Orangeburg, NY 10962 | |||
| Website | www.visionsciences.com/ | |||
| Country | United States | |||
| Year Founded | 1987 | |||
| Profitability | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -36.91% | |||
| Profit Margin | -42.09% | |||
| Management Effectiveness | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -35.79% | |||
| Return on Equity | -- | |||
| Income Statement | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 17.76M | |||
| Total Revenue (TTM) | 17.76M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 5.16M | |||
| EBITDA (TTM) | -5.93M | |||
| EBIT (TTM) | -6.56M | |||
| Net Income (TTM) | -7.48M | |||
| Net Income Avl. to Common (TTM) | -7.48M | |||
| Total Revenue Growth (Q YOY) | 9.16% | |||
| Earnings Growth (Q YOY) | 0.00% | |||
| EPS Diluted (TTM) | -0.81 | |||
| EPS Diluted Growth (Q YOY) | 0.47% | |||
| Balance Sheet | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.55M | |||
| Cash Per Share (Q) | $0.17 | |||
| Total Current Assets (Q) | 10.43M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -18.98M | |||
| Current Ratio (Q) | 2.699 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 3.87M | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | -18.98M | |||
| Cash Flow | CGNT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -47.00K | |||
| Cash from Financing (TTM) | 5.52M | |||
| Net Change in Cash (TTM) | 426.00K | |||
| Levered Free Cash Flow (TTM) | -1.58M | |||
| Cash from Operations (TTM) | -5.05M | |||
